Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Exelixis: Still Promising, Still Controversial
Exelixis: Still Promising, Still Controversial
Exelixis: Still Promising, Still Controversial
Submitted by
admin
on August 22, 2011 - 11:47am
Source:
Seeking Alpha
News Tags:
Exelixis
cabozantinib
Bone metastases
Headline:
Exelixis: Still Promising, Still Controversial
Do Not Allow Advertisers to Use My Personal information
